INC cozies up to site group; Gallus inks an ADC deal;

> INC Research has deepened its ties with the Society for Clinical Research Sites, a trade organization representing more than 1,500 R&D outposts in 37 countries. More

> CMO Gallus BioPharmaceuticals has signed a deal with Progenics Pharmaceuticals to manufacture armed antibody candidates for clinical development. News